Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-040694

CEO sold 4,767 shares at $15.47 ($73,750)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Shah Gaurav CEO 2023-08-17 Sale −4,767 $15.47 $73,750 524,854 D: show line 1 in the form
Open-market sales · 4,767 sh · avg $15.47 · $73,750
Loading xslF345X05/form4.xml…